Document is current
Any future updates will be listed below
-
Authors
Ghusn, Wissam
Ma, Pearl
Ikemiya, Kayla
Hage, Karl
Abboud, Donna Maria
Vierkant, Robert A.
Kendrick, Michael L.
Higa, Kelvin
Acosta, Andres
Ghanem, Omar M. https://orcid.org/0000-0002-5725-8497
- License Information
-
More Information
Article History
Received: 4 April 2023
Accepted: 30 May 2023
First Online: 13 June 2023
Declarations
:
: Andres Acosta reported receiving grants from the National Institute of Diabetes and Digestive and Kidney Diseases during the conduct of the study; holding stock in Gila Therapeutics and Phenomix Sciences; and serving as a consultant for Rhythm Pharmaceuticals, General Mills, and Amgen Pharmaceuticals outside the submitted work. Pearl Ma is a consultant for Ethicon, Medtronic and Intuitive. Kelvin Higa is a consultant for Medtronic and Ethicon. Wissam Ghusn, Kayla Ikemiya, Karl Hage, Donna Maria Abboud, Robert A. Vierkant, Michael L. Kendrick and Omar M. Ghanem report no disclosures or conflict of interests.
